PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
9.62%
Cash & equivalents yoy growth 5-10% – moderate liquidity gain. Seth Klarman would see it as a prudent buffer, potentially for acquisitions or uncertainty. Check capital allocation strategy.
No Data
No Data available this quarter, please select a different quarter.
9.62%
Cash + STI yoy growth 5-10% – moderate improvement. Seth Klarman would consider if it aligns with revenue growth and capital needs.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.08%
Growth 5-10% – moderate improvement. Seth Klarman would verify if the rise aligns with revenue expansion.
-7.18%
Declining PP&E may indicate underinvestment or asset sales. Seth Klarman would question future capacity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.96%
Growth 0-5% yoy – slight change. Peter Lynch wonders if the firm is cautious or sees limited investment opportunities.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.38%
Declining non-current assets may signal asset sales or underinvestment. Howard Marks would investigate future growth implications.
No Data
No Data available this quarter, please select a different quarter.
8.48%
5-10% yoy – moderate asset buildup. Seth Klarman sees typical reinvestment, verifying synergy with sales/earnings growth.
-5.53%
Declining payables indicates faster supplier payments but reduces free financing. Howard Marks would verify liquidity remains adequate.
-100.00%
Declining short-term debt reduces immediate leverage risk. Benjamin Graham would see this as improving financial safety.
No Data
No Data available this quarter, please select a different quarter.
6569.50%
Deferred revenue yoy ≥ 20% – strong advance billings. Warren Buffett would confirm sustainability of prepayments.
100.00%
Above 5% yoy – potential spike in near-term liabilities. Philip Fisher demands details on these obligations.
-5.06%
Declining current liabilities reduces short-term financial pressure. Seth Klarman would see this as improving liquidity position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2126.46%
Declining deferred tax liabilities reduces future tax burdens. Seth Klarman would see this as improving long-term cash flow outlook.
No Data
No Data available this quarter, please select a different quarter.
-0.39%
Declining total non-current liabilities reduces long-term leverage risk. Benjamin Graham would see this as strengthening the balance sheet.
No Data
No Data available this quarter, please select a different quarter.
-1.27%
Declining total liabilities strengthens the balance sheet. Howard Marks would see this as reducing financial risk.
3.57%
Up to 5% yoy – small issuance. Howard Marks asks if new capital is used productively.
-2.57%
Declining retained earnings signals net losses or large dividends. Seth Klarman would investigate the sustainability of dividend policy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.56%
Equity growth ≥ 10% yoy – a strengthening net worth. Warren Buffett checks if the ROE is healthy.
8.48%
8-12% yoy – strong increase. Warren Buffett sees potential growth if returns are adequate.
0.96%
0-5% yoy – slight change. Peter Lynch sees a cautious approach or fewer opportunities.
-6.20%
Declining total debt reduces leverage risk. Seth Klarman would see this as improving financial stability and flexibility.
-10.07%
Declining net debt indicates improving liquidity or deleveraging. Howard Marks would see this as strengthening financial position.